“Imatinib Mesylate in First-Line Treatment of Chronic Myeloid Leukemia ”. Annals of Medical Research 26, no. 9 (May 25, 2021): 1737–1743. Accessed April 4, 2025. http://annalsmedres.org/index.php/aomr/article/view/1748.